论文信息 - FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer - 字舞流文

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer

Reena Philip | R. Pazdur | L. Amiri-Kordestani | J. Beaver | P. Kluetz | J. Seidman | E. Bloomquist | J. Qiu | P. Song | N. Rahman | Jingyu Yu | A. Abukhdeir | Tiffany K Ricks | Y. Gong | Soma Ghosh | C. Osgood | Haw-Jyh Chiu | Tiffany K. Ricks | Sherry Hou | W. Pierce | Jennifer J. Gao | Xiling Jiang | Hui Zhang | V. Bhatnagar | F. Rizvi | W. Wilson